Program Overview 

We invite New Jersey Healthcare Professionals to join us for an engaging and informative program that explores the latest breakthroughs in liver disease management, cancer treatment, and transplantation. This educational event brings together leading experts to share insights on cutting-edge technologies, emerging therapies, and multidisciplinary approaches shaping the future of hepatology and liver surgery. Attendees will gain practical, evidence-based knowledge to enhance clinical decision-making and improve patient outcomes.

Learning Objectives:

• Identify groundbreaking innovations in liver surgery and transplantation, including machine liver perfusion, robotic-assisted procedures, AI applications, and xenotransplantation, and evaluate their potential impact on clinical practice.
• Understand the latest advancements in liver cancer treatment by reviewing current immunotherapy recommendations, emerging technologies like histosonics, and updates in LIRADS for liver tumor assessment.
• Discuss evolving strategies for managing common liver diseases, including new pharmacologic approaches for MASLD and alcohol-related liver disease, multidisciplinary transplant selection, and the latest AASLD guidelines and DDW highlights to improve patient care.

Target Audience

This program has been designed for oncology providers, including surgeons, physicians, fellows, residents, nurse practitioners, and physician assistants general & transplant surgery, oncology, immunology, pulmonology, cardiology, gastroenterology, infectious disease, neuroscience & radiology.